This webinar chaired by Dr. Ira Bleiwess, Chief of Breast Pathology at the University of Pennsylvania, and Dr. Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, will feature expert pathology and oncology perspectives on the management of triple-negative breast cancer (TNBC), including case explorations and insights into frequently asked questions. Register today to hear these expert perspectives!
In this live or virtual Visiting Faculty Series, expert speakers will provide insights and strategies for leveraging the growing arsenal of adjuvant therapies for early-stage non–small cell lung cancer (NSCLC), including treatment selection and adverse event management. Schedule a meeting for your institution today!
This live or Zoom-broadcasted hematology fellows lecture series can be scheduled today for your institution. Leading faculty will provide expert perspectives on optimizing the diagnosis, treatment, and supportive care of CAD. Schedule a meeting today!
This live or Zoom-broadcasted hematology/oncology fellows lecture series can be brought to your institution. Expert faculty will provide insightful guidance on current treatment standards and will discuss emerging therapies with the potential to improve patient outcomes in aTTP. Schedule a meeting today!
Schedule this live or virtual visiting faculty meeting series for your institution. Attendees will hear expert perspectives and practical guidance on treating HER2-positive metastatic colorectal cancer (CRC). Schedule a meeting today!
This live or Zoom-broadcasted hematology/oncology fellows lecture series will explore expert guidance on current standards and new directions in newly diagnosed multiple myeloma. Schedule a meeting today!
This live or virtual meeting can be scheduled to bring an expert faculty member to your institution to provide an in-depth discussion on current challenges and new opportunities in the management of acid sphingomyelinase deficiency (ASMD) in adults. Schedule a meeting today!
This live or virtual broadcasted activity will bring an expert faculty member to your hematology/oncology fellowship program to discuss the latest advances in BCMA-directed therapies for improved patent outcomes in relapsed/refractory multiple myeloma. Schedule a meeting today.
This live or virtual meeting series will bring an esteemed faculty member to present to your medical staff new insights and real-world evidence for improved patient outcomes in head and neck squamous cell carcinoma. Shedule a meeting today!
This live or zoom broadcasted hematology/oncology fellowship program will bring an expert faculty member to your institution to discuss developments and expert perspectives in the treatment of manle cell lymphoma.
This live meeting series will bring a leading clinical expert to your institution or virtually to discuss breaking developments in patient outcomes and treatment plans for patients with EGFR exon 20 insertion–mutant NSCLC.
Schedule this live or virtual visiting faculty meeting for your institution. Attendees will gain expert insight on the assessment of MM, emerging and current therapies, cutting edge approaches to personalized treatments plans, and much more.